Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine

Bibliographic Details
Title: Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
Authors: Danilo Di Bona, Andrea Miniello, Eustachio Nettis
Source: Clinical and Molecular Allergy, Vol 20, Iss 1, Pp 1-5 (2022)
Publisher Information: BMC, 2022.
Publication Year: 2022
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: Immunologic diseases. Allergy, RC581-607
More Details: Abstract Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1476-7961
Relation: https://doaj.org/toc/1476-7961
DOI: 10.1186/s12948-022-00179-8
Access URL: https://doaj.org/article/9b75288c0f1645bdb1b9f778ccde0c77
Accession Number: edsdoj.9b75288c0f1645bdb1b9f778ccde0c77
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14767961
DOI:10.1186/s12948-022-00179-8
Published in:Clinical and Molecular Allergy
Language:English